• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Improved immunogenicity against SARS-CoV-2 in a solid-organ transplant recipient by switching vaccines.

作者信息

Al Jalali Valentin, Scherzer Sabine, Zeitlinger Markus

机构信息

Department of Clinical Pharmacology, Medical University of Vienna, Austria.

Department of Cardiothoracic Surgery, Medical University of Vienna, Austria.

出版信息

Clin Microbiol Infect. 2021 Oct;27(10):1529-1530. doi: 10.1016/j.cmi.2021.06.022. Epub 2021 Jun 27.

DOI:10.1016/j.cmi.2021.06.022
PMID:34192576
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8236129/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/412b/8236129/dd6bf304989f/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/412b/8236129/dd6bf304989f/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/412b/8236129/dd6bf304989f/gr1_lrg.jpg

相似文献

1
Improved immunogenicity against SARS-CoV-2 in a solid-organ transplant recipient by switching vaccines.通过更换疫苗提高实体器官移植受者对严重急性呼吸综合征冠状病毒2（SARS-CoV-2）的免疫原性。
Clin Microbiol Infect. 2021 Oct;27(10):1529-1530. doi: 10.1016/j.cmi.2021.06.022. Epub 2021 Jun 27.
2
Randomized Trial of a Third Dose of mRNA-1273 Vaccine in Transplant Recipients.移植受者中第三剂mRNA-1273疫苗的随机试验。
N Engl J Med. 2021 Sep 23;385(13):1244-1246. doi: 10.1056/NEJMc2111462. Epub 2021 Aug 11.
3
SARS-CoV-2 Messenger RNA Vaccine Immunogenicity in Solid Organ Transplant Recipients With Prior COVID-19.严重急性呼吸综合征冠状病毒2型信使核糖核酸疫苗在曾感染2019冠状病毒病的实体器官移植受者中的免疫原性
Transplantation. 2021 Nov 1;105(11):e270-e271. doi: 10.1097/TP.0000000000003900.
4
Three Doses of an mRNA Covid-19 Vaccine in Solid-Organ Transplant Recipients.实体器官移植受者接种三剂mRNA新冠疫苗
N Engl J Med. 2021 Aug 12;385(7):661-662. doi: 10.1056/NEJMc2108861. Epub 2021 Jun 23.
5
Very Low Immunization Rate in Kidney Transplant Recipients After One Dose of the BNT162b2 Vaccine: Beware not to Lower the Guard!肾移植受者接种一剂BNT162b2疫苗后免疫率极低：谨防放松警惕！
Transplantation. 2021 Oct 1;105(10):e148-e149. doi: 10.1097/TP.0000000000003818.
6
Effect of antimetabolite regimen on cellular and humoral immune response to SARS-COV-2 vaccination in solid organ transplant recipients.抗代谢药物方案对实体器官移植受者接种 SARS-CoV-2 疫苗后细胞和体液免疫应答的影响。
Immunol Lett. 2024 Aug;268:106886. doi: 10.1016/j.imlet.2024.106886. Epub 2024 Jun 19.
7
Safety and Immunogenicity of a Third Dose of SARS-CoV-2 Vaccine in Solid Organ Transplant Recipients: A Case Series.实体器官移植受者接种第三剂新冠病毒疫苗的安全性和免疫原性：病例系列
Ann Intern Med. 2021 Sep;174(9):1330-1332. doi: 10.7326/L21-0282. Epub 2021 Jun 15.
8
Safety and Immunogenicity of Anti-SARS-CoV-2 Messenger RNA Vaccines in Recipients of Solid Organ Transplants.实体器官移植受者中抗SARS-CoV-2信使核糖核酸疫苗的安全性和免疫原性
Ann Intern Med. 2021 Sep;174(9):1336-1338. doi: 10.7326/M21-1341. Epub 2021 May 25.
9
A Fourth Dose of COVID-19 Vaccine Does Not Induce Neutralization of the Omicron Variant Among Solid Organ Transplant Recipients With Suboptimal Vaccine Response: Erratum.在疫苗反应欠佳的实体器官移植受者中，第四剂新冠疫苗无法诱导对奥密克戎变异株的中和作用：勘误
Transplantation. 2024 May 1;108(5):e78. doi: 10.1097/TP.0000000000005004. Epub 2024 Apr 24.
10
Cellular and Humoral Immune Responses After 3 Doses of BNT162b2 mRNA SARS-CoV-2 Vaccine in Kidney Transplant.肾移植受者接种 3 剂 BNT162b2 mRNA SARS-CoV-2 疫苗后的细胞和体液免疫反应
Transplantation. 2021 Nov 1;105(11):e267-e269. doi: 10.1097/TP.0000000000003903.

引用本文的文献

1
Comparison of the Immune Response After an Extended Primary Series of COVID-19 Vaccination in Kidney Transplant Recipients Receiving Standard Versus Mycophenolic Acid-sparing Immunosuppressive Regimen.接受标准免疫抑制方案与霉酚酸减量免疫抑制方案的肾移植受者在延长的新冠疫苗初级接种系列后的免疫反应比较
Transplant Direct. 2022 Oct 25;8(11):e1393. doi: 10.1097/TXD.0000000000001393. eCollection 2022 Nov.
2
Antibody Response and Adverse Events of AZD1222 COVID-19 Vaccination in Patients Undergoing Dialysis: A Prospective Cohort Study.AZD1222新冠疫苗在透析患者中的抗体反应及不良事件：一项前瞻性队列研究
Vaccines (Basel). 2022 Sep 3;10(9):1460. doi: 10.3390/vaccines10091460.

本文引用的文献

1
Mix-and-match COVID vaccines trigger potent immune response.混合搭配新冠疫苗引发强烈免疫反应。
Nature. 2021 May;593(7860):491. doi: 10.1038/d41586-021-01359-3.
2
Heterologous prime-boost COVID-19 vaccination: initial reactogenicity data.异源初免-加强型新型冠状病毒肺炎疫苗接种：初始反应原性数据
Lancet. 2021 May 29;397(10289):2043-2046. doi: 10.1016/S0140-6736(21)01115-6. Epub 2021 May 12.
3
Antibody response to SARS-CoV-2 mRNA vaccine among kidney transplant recipients: a prospective cohort study.肾移植受者对 SARS-CoV-2 mRNA 疫苗的抗体反应：一项前瞻性队列研究。
Clin Microbiol Infect. 2021 Aug;27(8):1173.e1-1173.e4. doi: 10.1016/j.cmi.2021.04.028. Epub 2021 May 3.
4
Antibody Response to 2-Dose SARS-CoV-2 mRNA Vaccine Series in Solid Organ Transplant Recipients.实体器官移植受者对两剂严重急性呼吸综合征冠状病毒2信使核糖核酸疫苗系列的抗体反应。
JAMA. 2021 Jun 1;325(21):2204-2206. doi: 10.1001/jama.2021.7489.